HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Protect IP To Encourage Switching In Australia, Urges ASMI

Executive Summary

The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia. 

You may also be interested in...



German Industry Wants To Simplify 'Complicated' Switch Process

The German Medicines Manufacturers´ Association, the BAH, is calling for the country's prescription-to-OTC reclassification procedure to be simplified by removing from the process the country's Ministry of Health and Bundesrat, and empowering the medicines agency, BfArM, to make the final decision based on recommendations from the Expert Advisory Committee for Prescription. 

Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy

The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.

Supplements Industry Under Threat In Australia With 'Made In' Claim Restrictions

Claiming a dietary supplement is 'Made in Australia' has become much harder, threatening the long term viability of a thriving industry, warns Complementary Medicines Australia.

Related Content

Topics

UsernamePublicRestriction

Register

RS148530

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel